Your browser doesn't support javascript.
loading
Reasons for PrEP Discontinuation After Navigation at Sexual Health Clinics: Interactions Among Systemic Barriers, Behavioral Relevance, and Medication Concerns.
Unger, Zoe D; Golub, Sarit A; Borges, Christine; Edelstein, Zoe R; Hedberg, Trevor; Myers, Julie.
Affiliation
  • Unger ZD; Department of Psychology, Hunter College, City University of New York, New York, NY.
  • Golub SA; Department of Psychology, Hunter College, City University of New York, New York, NY.
  • Borges C; Basic and Applied Social Psychology (BASP) PhD Program, Graduate Center of the City University of New York, New York, NY.
  • Edelstein ZR; Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR), New York, NY.
  • Hedberg T; New York City Department of Health and Mental Hygiene, Bureau of Public Health Clinics, New York, NY.
  • Myers J; New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV and STI, New York, NY.
J Acquir Immune Defic Syndr ; 90(3): 316-324, 2022 07 01.
Article in En | MEDLINE | ID: mdl-35286280
BACKGROUND: Pre-exposure prophylaxis (PrEP) for HIV prevention requires engagement throughout the PrEP care continuum. Using data from a PrEP navigation program, we examine reasons for PrEP discontinuation. SETTING: Participants were recruited from New York City Health Department Sexual Health Clinics with PrEP navigation programs. METHODS: Participants completed a survey and up to 3 interviews about PrEP navigation and use. This analysis includes 94 PrEP initiators that were PrEP-naive before their clinic visit, started PrEP during the study, and completed at least 2 interviews. Interview transcripts were reviewed to assess reasons for PrEP discontinuation. RESULTS: Approximately half of PrEP initiators discontinued PrEP during the study period (n = 44; 47%). Most participants (71%) noted systemic issues (insurance or financial problems, clinic or pharmacy logistics, and scheduling barriers) as reasons for discontinuation. One-third cited medication concerns (side effects, potential long-term side effects, and medication beliefs; 32%) and behavioral factors (low relevance of PrEP because of sexual behavior change; 34%) as contributing reasons. Over half (53.5%) highlighted systemic issues alone, while an additional 19% attributed discontinuation to systemic issues in combination with other factors. Of those who discontinued, approximately one-third (30%) restarted PrEP during the follow-up period, citing resolution of systemic issues or behavior change that increased PrEP relevance. CONCLUSIONS: PrEP continuation is dependent on interacting factors and often presents complex hurdles for patients to navigate. To promote sustained engagement in PrEP care, financial, clinic, and pharmacy barriers must be addressed and counseling and navigation should acknowledge factors beyond sexual risk that influence PrEP use.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Sexual Health / Pre-Exposure Prophylaxis Limits: Humans / Male Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Sexual Health / Pre-Exposure Prophylaxis Limits: Humans / Male Language: En Journal: J Acquir Immune Defic Syndr Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2022 Document type: Article Country of publication: United States